Redmile Group’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.5M Sell
1,237,659
-48,200
-4% -$1.34M 1.95% 10
2025
Q4
$35.6M Sell
1,285,859
-101,700
-7% -$2.59M 2.62% 10
2025
Q3
$33.7M Sell
1,387,559
-35,852
-3% -$713K 3.28% 11
2025
Q2
$24.2M Sell
1,423,411
-186,918
-12% -$3.26M 2.58% 13
2025
Q1
$31.4M Buy
1,610,329
+81,762
+5% +$2.14M 2.97% 11
2024
Q4
$37.9M Sell
1,528,567
-82,446
-5% -$2.1M 2.64% 12
2024
Q3
$39.5M Sell
1,611,013
-92,048
-5% -$2.38M 2.33% 19
2024
Q2
$39.9M Sell
1,703,061
-176,556
-9% -$4.34M 2.41% 15
2024
Q1
$62.1M Buy
1,879,617
+449,834
+31% +$14M 2.28% 14
2023
Q4
$38.9M Sell
1,429,783
-39,942
-3% -$992K 1.39% 23
2023
Q3
$35.3M Sell
1,469,725
-15,474
-1% -$415K 1.68% 19
2023
Q2
$47.4M Sell
1,485,199
-126,895
-8% -$4.12M 1.82% 15
2023
Q1
$49.4M Sell
1,612,094
-158,493
-9% -$6.25M 2.14% 14
2022
Q4
$69.2M Sell
1,770,587
-2,400
-0.1% -$107K 2.83% 10
2022
Q3
$84.5M Sell
1,772,987
-76,900
-4% -$4.39M 3.28% 7
2022
Q2
$71.6M Buy
1,849,887
+13,837
+0.8% +$550K 2.73% 8
2022
Q1
$105M Sell
1,836,050
-49,800
-3% -$3.27M 3.28% 9
2021
Q4
$150M Sell
1,885,850
-89,156
-5% -$7.63M 3.42% 8
2021
Q3
$172M Sell
1,975,006
-77,500
-4% -$7.79M 3% 9
2021
Q2
$264M Sell
2,052,506
-480,017
-19% -$38.2M 3.91% 3
2021
Q1
$203M Sell
2,532,523
-1,245,739
-33% -$119M 2.86% 6
2020
Q4
$308M Buy
3,778,262
+451,000
+14% +$22.2M 3.74% 4
2020
Q3
$81.9M Sell
3,327,262
-29,696
-0.9% -$737K 1.5% 21
2020
Q2
$94M Sell
3,356,958
-2,300
-0.1% -$49.6K 1.74% 16
2020
Q1
$60.5M Buy
+3,359,258
New +$73M 1.7% 17

Other funds holding BEAM